Pediatric Reference Intervals for Biochemical Markers: Gaps and Challenges, Recent National Initiatives and Future

Houman Tahmasebi1,2, Victoria Higgins1,2, Angela W S Fung2

  • 1CALIPER Program, Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada.

EJIFCC
|April 26, 2017
PubMed

Insights

Establishing accurate pediatric reference intervals is crucial for correct medical diagnosis. The Canadian CALIPER project is creating updated, age- and sex-specific benchmarks for biochemical markers to improve pediatric healthcare quality.

Area of Science:

  • Clinical Biochemistry
  • Pediatric Diagnostics
  • Laboratory Medicine

Background:

  • Reference intervals are essential benchmarks for interpreting laboratory test results in clinical decision-making.
  • Current pediatric reference intervals are often derived from adult or hospitalized populations, leading to inaccuracies.
  • Inappropriate reference intervals can result in misdiagnosis, delayed treatment, and compromised patient care.

Purpose of the Study:

  • To discuss challenges and deficiencies in establishing pediatric reference intervals for biochemical markers.
  • To review initiatives for creating pediatric reference intervals from healthy populations.
  • To highlight the Canadian CALIPER project's contributions to addressing these gaps.

Main Methods:

  • Review of early studies using hospitalized pediatric patients.
  • Examination of recent national and global initiatives focused on healthy pediatric populations.
  • Highlighting the establishment of a biobank and database by the CALIPER project.

Main Results:

  • Identified critical gaps and inappropriateness of existing pediatric reference intervals.
  • Demonstrated the success of the CALIPER project in establishing comprehensive pediatric reference intervals.
  • CALIPER has created a biobank and database to support accurate pediatric diagnostics.

Conclusions:

  • Updating pediatric reference intervals based on age and sex is imperative for accurate diagnosis and treatment.
  • The CALIPER project provides a valuable resource for comprehensive pediatric reference intervals.
  • Dissemination of CALIPER data through publications, databases, and applications will improve global pediatric diagnostics.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
294
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
446
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
457